Aster Capital Management DIFC Ltd purchased a new stake in Amrize Ltd (NYSE:AMRZ – Free Report) in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm purchased 9,600 shares of the company’s stock, valued at approximately $519,000.
A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in AMRZ. Geode Capital Management LLC purchased a new stake in Amrize in the second quarter valued at about $265,000. M&T Bank Corp purchased a new stake in Amrize in the second quarter valued at about $205,000. Arrowstreet Capital Limited Partnership purchased a new stake in Amrize in the second quarter valued at about $3,870,000. Gabelli Funds LLC acquired a new position in shares of Amrize in the second quarter valued at about $1,083,000. Finally, AXA S.A. acquired a new position in shares of Amrize in the second quarter valued at about $1,065,000.
Wall Street Analyst Weigh In
A number of research analysts have recently weighed in on the company. Truist Financial cut their price objective on Amrize from $75.00 to $65.00 and set a “buy” rating on the stock in a report on Friday, May 1st. Citigroup cut their price objective on Amrize from $76.00 to $66.00 and set a “buy” rating on the stock in a report on Monday, May 4th. Morgan Stanley reissued an “overweight” rating and issued a $65.00 price objective on shares of Amrize in a report on Wednesday, May 6th. Stephens reissued an “overweight” rating and issued a $65.00 price objective on shares of Amrize in a report on Monday, May 18th. Finally, Vertical Research raised Amrize from a “hold” rating to a “buy” rating and set a $70.00 price objective on the stock in a report on Friday, May 1st. One equities research analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating and six have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $64.86.
Amrize Stock Up 1.6%
Amrize stock opened at $54.00 on Tuesday. The firm has a market cap of $29.87 billion and a price-to-earnings ratio of 25.84. Amrize Ltd has a 52 week low of $44.12 and a 52 week high of $65.94. The business’s 50-day moving average price is $54.07 and its 200 day moving average price is $55.53. The company has a quick ratio of 0.89, a current ratio of 1.40 and a debt-to-equity ratio of 0.38.
Amrize (NYSE:AMRZ – Get Free Report) last posted its earnings results on Wednesday, April 29th. The company reported ($0.16) EPS for the quarter, missing the consensus estimate of ($0.14) by ($0.02). The company had revenue of $2.18 billion for the quarter. Amrize had a return on equity of 9.84% and a net margin of 9.70%.The company’s revenue for the quarter was up 4.7% compared to the same quarter last year. As a group, sell-side analysts anticipate that Amrize Ltd will post 2.76 earnings per share for the current year.
Amrize Cuts Dividend
The firm also recently declared a dividend, which was paid on Wednesday, May 20th. Shareholders of record on Tuesday, May 12th were given a dividend of $0.11 per share. The ex-dividend date was Tuesday, May 12th. Amrize’s dividend payout ratio is currently 21.05%.
Insiders Place Their Bets
In other Amrize news, CTO Roald Brouwer purchased 1,500 shares of the stock in a transaction on Thursday, May 21st. The shares were bought at an average price of $49.84 per share, for a total transaction of $74,760.00. Following the completion of the transaction, the chief technology officer owned 19,757 shares of the company’s stock, valued at $984,688.88. This trade represents a 8.22% increase in their position. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, insider Nollaig Forrest purchased 2,000 shares of the stock in a transaction on Friday, May 22nd. The shares were acquired at an average price of $50.25 per share, for a total transaction of $100,500.00. Following the transaction, the insider directly owned 20,139 shares of the company’s stock, valued at $1,011,984.75. This represents a 11.03% increase in their position. The SEC filing for this purchase provides additional information. Over the last ninety days, insiders have purchased 54,920 shares of company stock worth $2,717,429. Company insiders own 0.54% of the company’s stock.
Amrize Company Profile
Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.
Featured Stories
- Five stocks we like better than Amrize
- These 5 Companies Just Made a Massive Bet on Themselves
- 5 Stocks Built to Thrive in a Higher-for-Longer Economy
- RH’s Strong Q1 Still Leaves Investors With One Big Question
- Iran Ceasefire or Not, These 3 Companies Could Win
Want to see what other hedge funds are holding AMRZ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amrize Ltd (NYSE:AMRZ – Free Report).
Receive News & Ratings for Amrize Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amrize and related companies with MarketBeat.com's FREE daily email newsletter.
